Building the SynBio community in the Czech Republic from the bottom up: You get what you give

Investor logo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Science. Official publication website can be found on muni.cz.
Authors

JURAČKA Stanislav HRNČÍŘOVÁ Barbora BURÝŠKOVÁ Barbora GEORGIEV Daniel DVOŘÁK Pavel

Year of publication 2022
Type Article in Periodical
Magazine / Source Biotechnology Notes
MU Faculty or unit

Faculty of Science

Citation
Web https://www.sciencedirect.com/science/article/pii/S2665906922000137
Doi http://dx.doi.org/10.1016/j.biotno.2022.11.002
Keywords Synthetic biology; Czech Republic; EU13 countries; Community; iGEM; Research landscape; Biotechnology and bioengineering; Public perception
Description Given its highly innovative character and potential socioeconomic impact, Synthetic Biology is often ranked among prominent research areas and national research priorities in developed countries. The global evolution of this field is proceeding by leaps and bounds but its development at the level of individual states varies widely. Despite their current satisfactory economic status, the majority of 13, mostly post-communist, countries that entered the European Union family in and after 2004 (EU13) have long overlooked the blossoming of Synthetic Biology. Their prioritized lines of research have been directed elsewhere or “Synthetic Biology” did not become a widely accepted term to encompass their bioengineering and biotechnology domains. The Czech Republic is not an exception. The local SynBio mycelium already exists but is mainly built bottom-up through the activities of several academic labs, iGEM teams, and spin-off companies. In this article, we tell their individual stories and summarize the prerequisites that allowed their emergence in the Czech academic and business environment. In addition, we provide the reader with a brief overview of laboratories, research hubs, and companies that perform biotechnology and bioengineering-oriented research and that may be included in a notional “shadow SynBio community” but have not yet adopted Synthetic Biology as a unifying term for their ventures. We also map the current hindrances for a broader expansion of Synthetic Biology in the Czech Republic and suggest possible steps that should lead to the maturity of this fascinating research field in our country.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.